Unlike forward design and high-throughput screening, inverse design works backward from target properties to molecular structures, offering a new paradigm for developing organic emissive materials.

Sanofi is buying Vicebio, a biotech, that is developing vaccines for two viruses using the molecular clamp technology invented at the University of Queensland.

University conducts research to establish conceptual, detailed design methodologies applicable to UAM systems and to develop digital twin technologies.